Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Four state-of-the-art large language models ...
OREM, Utah--(BUSINESS WIRE)--Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion ™ (research use only ...
BOSTON--(BUSINESS WIRE)--Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is proud to announce that its cutting-edge generative AI co-pilot, PathChat DX, has ...
BOSTON & WATERLOO, Ontario, July 29, 2025--(BUSINESS WIRE)--Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, and illumiSonics Inc., a leader in label-free ...
Modella AI’s PathChat Obtains FDA Breakthrough Device Designation For Advancing Pathology Diagnostic
KUALA LUMPUR, Feb 3 (Bernama) -- Modella AI, a pioneer in generative and agentic artificial intelligence (AI) for biomedicine, has announced that its cutting-edge generative AI co-pilot, PathChat DX, ...
Techcyte and Modella AI Announce a Research Collaboration with Modella AI's State-of-the-Art Agentic and Generative AI-Powered Diagnostic Pathology Platform Techcyte, a leading provider of AI-powered ...
Modella AI’s PathChat Obtains FDA Breakthrough Device Designation For Advancing Pathology Diagnostic
PathChat 2a (research use only) is capable of patch, slide and case level reasoning. (Graphic: Business Wire) KUALA LUMPUR, Feb 3 (Bernama) -- Modella AI, a pioneer in generative and agentic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results